Medtronic, Inc. (NYSE:MDT)
| CAPS Rating |
|
|---|---|
| Open | $39.69 |
| Previous Close | $39.93 |
| Daily Range | $39.33 - $39.78 |
| 52-Week Range | $30.18 - $43.33 |
| Market Cap | $41.95B |
| P/E Ratio | 11.70 |
| Dividend (Yield) | 0.97 (1.90%) |
| Volume | 5,140,330 |
| Average Daily Volume | 0 |
MDT
VS S&P 500 (SPY)
How do you think MDT will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
MDT Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
MDT News and Commentary
- Integra's New Extremity Offering - Analyst Blog – NASDAQ
- Earnings Scorecard: St. Jude - Analyst Blog – NASDAQ
- EW Misses on Revs, 1Q Guidance Weak - Analyst Blog – NASDAQ
- The Zacks Analyst Blog Highlights: Medtronic, Edwards Lifesciences, Boston Scientific, St Jude Medic – NASDAQ
- Positive Outcome on MDT's CoreValve - Analyst Blog – NASDAQ
- Medical Device Makers To Double FDA Fees: Sources - Bloomberg News – SmartMoney
- What Medtronic Does With Its Cash – The Motley Fool
- Earnings Preview: Boston Scientific - Analyst Blog – NASDAQ
- Outperform on ZOLL Medical - Analyst Blog – NASDAQ
- Judge Affirms Rulings Denying Medtronic, NuVasive Motions – SmartMoney
- Is Medtronic's Growth for Real? – The Motley Fool
- The Zacks Analyst Blog Highlights: Medtronic, Edwards Lifesciences, Boston Scientific, St Jude Medic – NASDAQ
- UPDATE: Court Denies Medtronic, NuVasive Motions Before Hearing – SmartMoney
- MDT Advances in CoreValve US Trial - Analyst Blog – NASDAQ
- Court Denies Medtronic, NuVasive Motions Ahead of Hearing Thursday – SmartMoney
- NuVasive Shares Popped: What You Need to Know – The Motley Fool
- St. Jude Beats, Charges Hurt Net - Analyst Blog – NASDAQ
- The Good and Bad of Johnson & Johnson – Blogs @ The Motley Fool
- The Good and Bad of Johnson & Johnson – Blogs @ The Motley Fool
- Earnings Preview: St. Jude - Analyst Blog – NASDAQ
RSS Headlines
Fool UK
